image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Primary Recommendations

Creo Medical - Very interesting special situation

March 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CREO
  • Price:
  • 27p
On SCSW I might typically meet between 15-20 companies in any given month and I make my final cut for the two main write ups just a few days before I put each issue to bed, after considering market conditions and possible newsflow coming from each company. Sometimes, I may have been trying to arrange one of my meetings for weeks and can end up burning the midnight oil if it finally falls late in the month; at other times, I can meet with a company thinking it is “the one” but afterwards might hold back from publication if I feel subscribers would be better off waiting. Sometimes this wait can be months. One where my wait-to-buy has been years not months is Creo, a life sciences company focusing on the commercialisation of minimally invas ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Creo (October 2023)
Creo (July 2023)
Creo (May 2023)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW